On the pulmonary toxicity of oxygen: III. The induction of oxygen dependency by oxygen use

Experimental and Molecular Pathology

Volumn 89, Issue 1, 2010, Pages 36-45

  Shanklin, D R ^a  

^a MARINE BIOLOGICAL LABORATORY   (United States)

Author keywords

Animal models for human disease; Area under the curve analysis; Bilateral cervical vagotomy; Hyaline membrane disease; Lung injury; Metabolic dependency; Oxygen toxicity; Respiratory distress syndrome; Semi log graphics

Indexed keywords

OXYGEN;

AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL RABBIT; HYALINE MEMBRANE DISEASE; LUNG LESION; LUNG TOXICITY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NONHUMAN; OXYGENATION; PERINATAL PERIOD; SURVIVAL; VAGOTOMY;

ANIMALS; ANIMALS, NEWBORN; ENVIRONMENTAL EXPOSURE; FEMALE; LUNG INJURY; OXYGEN; PREGNANCY; RABBITS; RESPIRATORY INSUFFICIENCY; RESPIRATORY MECHANICS; SURVIVAL RATE; VAGOTOMY;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 77954036140     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.05.004     Document Type: Article

References (77)

1. Abdel-Latif M.E., Osborn D.A., Challis D. Intra-amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns. Cochrane Database Syst. Rev. 2010, 20:CD007916.
2. Allen J.E., Rasmussen H. The effects of oxygen on cellular metabolism. Int. J. Clin. Pharm. 1971, 5:25-33.
3. Ambrus C.M., Pickren J.W., Weintraub D.H., Niswander K.R., Ambrus J.L., Rodbard D., Levy J.C. Studies on hyaline membrane disease. V. Oxygen induced hyaline membrane disease in guinea pigs. Biol. Neonat. 1968, 12:246-260.
4. Balentine J.D. Pathology of Oxygen Toxicity 1982, 129-140. Academic Press, New York.
5. Barach A.L. Physiologic Therapy in Respiratory Diseases 1948, 303-311. Lippincott, Philadelphia.
6. Blumenthal Y.J., Lyell D.J. Prematurity prevention: the role of acute tocolysis. Curr. Opin. Obstet. Gynecol. 2009, 21:136-141.
7. Bolande R.P., Kalus M.H. The morphologic demonstration of an alveolar lining layer and its relationship to pulmonary surfactant. Am. J. Pathol. 1964, 45:449-463.
8. Chang C.T., Wong R.L. Optimal selection procedures for abbreviated area under the curve (AAUC) of blood concentration versus time for drug blood concentration levels. J. Biopharm. Stat. 1998, 8:407-416.
9. Chess P.R., D'Angio C.T., Pryhuber G.S., Maniscalco W.M. Pathogenesis of bronchopulmonary dysplasia. Semin. Perinatol. 2006, 30:171-178.
10. Claireaux A.E. The effect of oxygen on the lung. J. Clin. Pathol. 1975, 28(supp. 9):75-80.
11. Cogswell J.J., Hatch D.J., Kerr A.A., Taylor B. Effects of continuous positive airway pressure on lung mechanics of babies after operation for congenital heart disease. Arch. Dis. Childh. 1975, 50:799-804.
12. Collard K.J., Godeck S., Holley J.E., Quinn M.W. Pulmonary antioxidant concentrations and oxidative damage in ventilated premature babies. Arch. Dis. Child. Fetal Neonatal Ed. 2004, 89:F412-F416.
13. Cools F., Askie L.M., Offringa M. Elective high-frequency oscillatory ventilation in preterm infants with respiratory distress syndrome: an individual patient data meta-analysis. BMC Pediatr. 2009, 9:33-45.
14. Crompton D.W.T., Shrimpton D.H., Silver A.I. Measurements of the oxygen tension in the lumen of the small intestine of the domestic duck. J. Exp. Biol. 1965, 43:473-478.
15. Cross C.E., van der Vliet A., O'Neill C.A., Louie S., Halliwell B. Oxidants, antioxidants, and respiratory lining fluids. Environ. Health Perspect. 1994, 102(Supp. 10):185-191.
16. Da-Silva S.S., Dellinger R.P. Inhaled nitric oxide: another weapon in out armementarium in the battle against acute hypoxic respiratory failure in preterm infants. Crit. Care 2004, 8:77-79.
17. deMello D.E., Chi E.Y., Doo E., Lagunoff D. Absence of tubular myelin in lungs of infants dying with hyaline membrane disease. Am. J. Pathol. 1987, 127:131-139.
18. Downs J.B., Klein E.F., Desautels D., Modell J.H., Kirby R.R. Intermittent mandatory ventilation: a new approach to weaning patients from mechanical ventilators. Chest 1973, 64:331-335.
19. Egan D.F. Fundamentals of Respiratory Therapy 1977, 448-449. Mosby, St. Louis, IRDS.
20. Egan D.F. Fundamentals of Respiratory Therapy 1977, 379-385. Mosby, St. Louis, Ventilation generally.
21. Egan D.F. Fundamentals of Respiratory Therapy 1977, 456-460. Mosby, St. Louis, Weaning.
22. Egan D.F. Fundamentals of Respiratory Therapy 1977, 385-387. Mosby, St. Louis, Metabolic aspects.
23. Egan D.F. Fundamentals of Respiratory Therapy 1977, 291-298. Mosby, St. Louis, Oxygen and ventilation inseparability.
24. Fisher A.B., Dodia C., Tan Z., Ayene I., Eckenhoff R.G. Oxygen-dependent lipid peroxidation during lung ischemia. J. Clin. Invest. 1991, 88:674-679.
25. Frank L., Autor A.P., Roberts R.J. Oxygen therapy and hyaline membrane disease: the effect of hyperoxia on pulmonary superoxide dismutase activity and the mediating role of plasma or serum. J. Pediat. 1977, 90:105-110.
26. Frank L., Bucher J.R., Roberts R.J. Oxygen toxicity in neonatal and adult animals of various species. J. Appl. Physiol. 1978, 45:699-704.
27. Gregory G.A., Kitterman J.A., Phibbs R.H., Tooley W.H., Hamilton W.K. Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N. Eng. J. Med. 1971, 284:1333-1340.
28. Han R.N.N., Buch S., Tseu I., Young J., Christie N.A., Frndova H., Lye S.J., Tanswell A.K. Changes in structure, mechanics, and insulin-like growth factor-related gene expression in lungs of newborn rats exposed to air or 60% oxygen. Pediat. Res. 1996, 39:921-929.
29. Hardin J., Carmichael S.L., Selvin S., Shaw G.M. Trends in the probability of twins and males in California. Twin Res. Hum. Genet. 2009, 12:93-102.
30. Higgins R.D., Bancalari E., Willinger M., Raju T.N.K. Executive summary of the workshop on oxygen neonatal therapies: controversies and opportunities for research. Pediatrics 2007, 119:790-796.
31. Ingalls T.H. Epidemiology of retrolental fibroplasia; its etiologic relation to pulmonary hyaline membrane. N. Eng. J. Med. 1954, 251:1017-1022.
32. Jonxis J.H.P., van der Vlugt J.J., de Groot C.J., Boersma E.R., Meijers E.D.K. The metabolic rate in praemature, dysmature and sick infants in relation to environmental temperature. Nutricia Symposium, Aspects of Prematurity and Dysmaturity 1968, 201-209. CC Thomas, Springfield, Illinois. J.H.P. Jonxis, H.K.A. Visser, J.A. Troelstra (Eds.).
33. Kaarteenaho-Wiik R., Kinnula V.L. Distribution of antioxidant enzymes in developing human lung, respiratory distress syndrome, and bronchopulmonary dysplasia. J. Histochem. Cytochem. 2004, 52:1231-1240.
34. Kelly F.J., Lubec G. Hyperoxic injury of immature guinea pig lung is mediated via hydroxyl radicals. Pediat. Res. 1995, 38:286-291.
35. Kwan M., Niinikoski J., Hunt T.K. In vivo measurements of oxygen tension in the cornea, aqueous humor, and anterior lens of the open eye. Invest. Ophthal. 1972, 11:108-114.
36. Langley S.C., Kelly F.J. Depletion of pulmonary glutathione using diethylmaleic acid accelerates the development of oxygen-induced lung injury in term and preterm guinea-pig neonates. J. Pharm. Pharmacol. 1994, 46:98-102.
37. Le Floch J.P., Escuyer P., Baudin E., Baudon D., Perlemuter L. Blood glucose area under the curve. Methodological aspects. Diab. Care 1990, 13:172-175.
38. Lyra P.P., Diniz E.M. The importance of surfactant on the development of neonatal pulmonary diseases. Clinic (Sao Paulo) 2007, 62:181-190.
39. Martin J.A., Kirmeyer S., Osterman M., Shepherd R.A. Born a bit too early: recent trends in late preterm births. NCHS Data Brief, November, 1-8 2009.
40. McGrath J.C., MacLennan S.J., Mann A.C., Stuart-Smith K., Whittle M.J. Contraction of human umbilical artery, but not vein, by oxygen. J. Physiol. 1986, 380:513-519.
41. Morken N.H. Time to focus on the public health aspects of preterm delivery. Acta Obstet. Gynecol. Scand. 2010, 89:165-167.
42. Morley C.J., Davis P.G. Continuous positive airway pressure: scientific and clinical rationale. Curr. Opin. Pediat. 2008, 20:119-124.
43. Mortoloa J.P. Comparative aspects of the dynamics of breathing in newborn mammals. J. Appl. Physiol. 1983, 54:1229-1235.
44. Moss A.J., Emmanouilides G.C., Rettori O., Higashino S.M., Adams F.H. Postnatal circulatory and metabolic adjustments in normal and distressed premature infants. Biol. Neonat. 1965, 8:177-197.
45. Nash G., Blennerhassett J.B., Pontoppidan H. Pulmonary lesions associated with oxygen therapy and artificial ventilation. N. Eng. J. Med. 1967, 276:368-374.
46. Nishiki K., Jamieson D., Oshino N., Chance B. Oxygen toxicity in the perfused rat liver and lung under hyperbaric conditions. Biochem. J. 1976, 160:343-355.
47. Northway W.H., Rosan R.C. Oxygen therapy hazards in the neonate. Hosp. Pract. 1969, 4:59-67. January.
48. Northway W.H., Rosan R.C., Porter D.Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. N. Eng. J. Med. 1967, 276:357-368.
49. Northway W.H., Rosan R.C., Shaninian L., Castellino R.A., Gyepes M.T., Durbridge T. Radiologic and histologic investigation of pulmonary oxygen toxicity in newborn guinea pigs. Invest. Radiol. 1969, 4:148-155.
50. Orzalesi M.M., Mendicini M., Bucci G., Scalamandre A., Savignoni P.G. Arterial oxygen studies in premature newborns with and without mild respiratory disorders. Arch. Dis. Childh. 1967, 42:174-180.
51. Petrou S., Edwards L. Cost effectiveness analysis of neonatal extracorporeal membrane oxygenation based on four years results from the UK Collaborative ECMO trial. Arch. Dis. Child. Fetal Neonatal Ed. 2004, 89:F263-F268.
52. Phillips G.J., Mohammed W., Kelly F.J. Oxygen-induced lung injury in the pre-term guinea pig: the role of leukotriene B4. Respir. Med. 1995, 89:607-613.
53. Robertson B., Tunell R., Rudhe U. Late stages of pulmonary hyaline membrane of the newborn. Acta Paediatr. 1964, 53:433-446.
54. Rudolph A.M., Heymann M.A. The circulation of the fetus in utero. Methods for studying distribution of blood flow, cardiac output and organ blood flow. Cir. Res. 1967, 21:163-184.
55. Sahn S.A., Lakshminarayan S., Petty T.L. Weaning from mechanical ventilation. J.A.M.A. 1976, 235:2208-2212.
56. Schock B.C., Sweet D.G., Halliday H.L., Young I.S., Ennis M. Oxidative stress in lavage fluid of preterm infants at risk of chronic lung disease. Am. J. Physiol. Cell Mol. Physiol. 2001, 281:L1386-L1391.
57. Schwartz R., Adam P.A.J., King K., Kornhauser D. Glucose control in the newborn infant. Nutricia Symposium, Aspects of Praematurity and Dysmaturity 1968, 225. Charles C Thomas, Springfield, Illinois. J.H.P. Jonxis, H.K.A. Visser, J.A. Troelstra (Eds.).
58. Scopes J.W., Ahmed I. Minimal rates of oxygen consumption in sick and premature newborn infants. Arch. Dis. Child. 1966, 41:407-416.
59. Shanklin D.R. Oxytocin induction in pregnant rabbits. Am. J. Obstet. Gynec. 1966, 94:242-248.
60. Shanklin D.R. On the pulmonary toxicity of oxygen. I. The relationship of oxygen content to the effect of oxygen on the lung. Lab. Invest. 1969, 21:439-448.
61. Shanklin D.R. Oxygen and the lungs of newborn infants. Int. J. Clin. Pharm. 1971, 5:20-25.
62. Shanklin D.R. On the treatment of the idiopathic respiratory distress syndrome. Clin. Pediat. 1971, 10:434-438.
63. Shanklin D.R. Evidence for oxygen control of survival and for oxygen dependency in newborn rabbits. Clin. Res. 1972, 20:111.
64. Shanklin D.R., Berman P.A. An experimental model for hyaline membrane disease. Biol. Neonat. 1964, 6:340-360.
65. Shanklin D.R., Lester E.P. On the pulmonary toxicity of oxygen. II. The effect of the second gas. Biol. Neonate 1972, 20:140-158.
66. Shanklin D.R., O'Dell T.E. Ascorbic acid and the lung. Nature 1966, 210:1329-1331.
67. Shanklin D.R., Sotelo-Avila C. The effects of components of vagotomy on the lung and the effects of anesthesia on vagotomy induced lung change. Biol. Neonat. 1967, 11:61-86.
68. Shanklin D.R., Wolfson S.L. Therapeutic oxygen as a possible cause of pulmonary hemorrhage in premature infants. N. Eng. J. Med. 1967, 277:833-837. see also: Editorial, ibid 277: 878-879 (1967); correspondence, ibid 278:338 (1968).
69. Shanklin D.R., Wolfson S.L. Aqueous estrogens in the management of respiratory distress syndrome. J. Reprod. Med. 1970, 5:53-71.
70. Shanklin D.R., Cunningham J.J., Sotelo-Avila C., Crussi F. Oxygen, ascorbic acid, and the lung. Arch. Pathol. 1967, 84:451-459.
71. Shanklin D.R., Mullins A.C., Baldwin H.S. Cerebropulmonary dysgenetic syndrome. Exp. Mol. Pathol. 2008, 85:112-116.
72. Sunderam S., Chang J., Flowers L., Kulkarni A., Sentelle G., Jeng G., Macaluso M. Assisted reproductive technology surveillance - United States. MMWR Surveill. Summ. 2009, 58:1-25.
73. Taylor J.P. Manual of Respiratory Therapy 1978, 99-116. Mosby, St. Louis. 2nd ed.
74. te Pas A.B., Lopriore E., Engbers M.J., Walther F.J. Early respiratory management of respiratory distress syndrome in very preterm infants and bronchoplumonary dysplasia: a case-control study. PLoS One 2007, 2:e192.
75. Turrens J.F., Crapo J.D., Freeman B.A. Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J. Clin. Invest. 1984, 73:87-95.
76. Urschitz M.S., Horn W., Seyfang A., Hallenberger A., Herberts T., Miksch S., Popow C., Müller-Hansen I., Poets C.F. Automatic control of the inspired oxygen fraction in preterm infants. Am. J. Respir. Crit. Care Med. 2004, 170:1095-1100.
77. Winternitz M.C., Meloy C.R. On the occurrence of catalase in human tissues and its variation in disease. J. Exp. Med. 1908, 10:759-781.